Navigation Links
SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc.
Date:3/31/2008

ility to complete the offer or the merger due to the failure to satisfy the conditions to the offer and the merger, including SXC's receipt of financing, the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the receipt of other required regulatory approvals; (4) risks that the proposed transaction disrupts current plans and operations and potential difficulties in employee retention as a result of the offer or the merger; (5) the ability to recognize the benefits of the merger; (6) the actual terms of the financing obtained in connection with the offer and the merger; (7) legislative, regulatory and economic developments; and (8) other factors described in filings with the SEC. Many of the factors that will determine the outcome of the subject matter of this communication are beyond NMHC's and SXC's ability to control or predict. The companies can give no assurance that any of the transactions related to the offer will be completed or that the conditions to the offer and the merger will be satisfied. The companies undertake no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. The companies are not responsible for updating the information contained in this communication beyond the published date, or for changes made to this communication by wire services or Internet service providers.


'/>"/>
SOURCE SXC Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Governor Rendell Proposes County Grants to Combat West Nile Virus, Protect Public Health
2. CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization
3. Mental Health Advocates Rally to Raise the $60
4. Streamline Health Solutions, Inc. Reports Fourth Quarter and Fiscal Year 2007 Results
5. The United States Patent and Trademark Office Grants TransUnion Patent for Healthcare Financing Method
6. Communicating your way to a healthy heart
7. Grubb & Ellis Healthcare REIT Acquires Epler Parke Building B in Indianapolis
8. American Heart Association Teams Up With the Presidents Council on Physical Fitness and Sports to Promote Physical Activity and Healthy Eating
9. eq-life(R) and Fairview Pharmacy Services Announce Multi-Year Consulting Contract with Alegent Health
10. Healthcare Workers Across California Vote to Join UHW
11. Debate Will Feature Clinton-Obama Positions on Health Care Followed by Straw Poll
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)... Mo. There is no cure for spinal muscular atrophy...ng of muscles and is the leading genetic cause of ...rs have discovered a new therapeutic target that i...d by SMA. The new therapy enhanced muscle strength...fespan in a SMA model. , "This therapy does no...
(Date:1/7/2009)...Illinois and Jerusalem, Israel, January 7, 2009 --... - Teva Joint Venture (JV) announced today that Ch...cer centers in Europe, the United States and Israe...y. The pivotal registration study is testing the s...ive transplantation option for adolescents and adu...
(Date:1/7/2009)...PLAINS, N.J., Jan. 7 Im...utical company focused on developing monoclonal an...s, today announced that Cynthia L. Sullivan, Presi...ng at the 27th Annual J.P. Morgan Healthcare Confe...Sullivan,s presentation, which is scheduled for Th...
(Date:1/7/2009)..., Free fully customizable diet plan offered by Dr....- Timothy S. Harlan, M.D., also known as Dr. Gourm... customizable diet and menu planning software , w...user/login.php The name of the plan reflects Dr. ...ealthy, delicious foods - are the key to eating he...
Breaking Medicine News(10 mins):Health News:Researchers discover target that could ease spinal muscular atrophy symptoms 2Health News:Children's Memorial Hospital, Chicago, joins ExCell study 2Health News:Immunomedics to Present at 27th Annual J.P. Morgan Healthcare Conference 2Health News:Immunomedics to Present at 27th Annual J.P. Morgan Healthcare Conference 3Health News:Dr. Gourmet Launches The Quality Calorie Diet Plan - Free Online Meal Planning Software 2Health News:Dr. Gourmet Launches The Quality Calorie Diet Plan - Free Online Meal Planning Software 3
...l is the hardest tissue produced by the body. It c... layer of cells that is lost by the time the tooth...nder of its lifetime vulnerable to wear, damage, a...xciting to consider the prospect of artificially g...
...al and motivational video, designed to increase em...low vision patients increased knowledge but did no...While our video clearly succeeded in increasing pa...ion and the availability of adaptive devices and t...
...tial chemotherapy treatment, radiation may be a be...IIA non-small-cell lung cancer, //according to a r...l of the National Cancer Institute. The authors su...py and radiation should be the preferred treatment...
...uctal adenocarcinoma is an almost uniformly fatal ...is. However, a small percentage //of patients deve...h cystic lesions that can be detected earlier, is ...rvival rate. Why cystic ductal pancreatic cancer b...
Other Medicine News:Health News:Scientists Re-grow Dental Enamel from Cultured Cells 2Health News:Educational Video Increases Knowledge but Not Behavior 2Health News:Educational Video Increases Knowledge but Not Behavior 3Health News:Radiation Preferred Over Surgery for Patients With Some Stages of Lung Cancer 2Health News:Genetic Pathways to Curable and Incurable Forms of Pancreatic Cancer Identified 2Health News:Genetic Pathways to Curable and Incurable Forms of Pancreatic Cancer Identified 3
(Date:12/17/2008)...r the first time that normal stem cells can act as... , MEMPHIS, Tenn., Dec. 17 /PRNewswire-USNewsw...ch Hospital have answered a central question in ca...ise to tumors. Stem cells are immature cells that ...rentiated cells that compose the range of body tis...
(Date:12/17/2008)...ire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: ...R. Contag, Ph.D., to Delcath,s Board of Directors....extensive experience working with international an.../www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO...ies, Inc. in 2006 and served as CEO. Prior to sta...
(Date:12/16/2008)...Between Inflammation & Alzheimer,s Disease , ...e Roskamp Institute today announced that its resea...ion and Alzheimer,s disease and have identified a ... for intervention in this disease. The study, led...detailed in the American Chemical Society,s Chemi...
(Date:12/15/2008)...18, 2008 at 9 a.m. Eastern Time , , VALENC...nnKind Corporation (Nasdaq: MNKD ) will host a ... final two Phase 3 studies of AFRESA(TM), the comp... at 9 a.m. Eastern Time on Thursday, December 18, ... by telephone, please dial (888) 677-5721 or (210)...
Breaking Medicine Technology:Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 3Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 3MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 2Rigel Announces Pricing of Public Offering of Common Stock 2924 1Rigel Announces Pricing of Public Offering of Common Stock 2924 2Lose Weight Gain Life 3A New Website to Help People Seeking Information on Obesity Surgery 10704 1Lose Weight Gain Life 3A New Website to Help People Seeking Information on Obesity Surgery 10704 2Lose Weight Gain Life 3A New Website to Help People Seeking Information on Obesity Surgery 10704 3FDA Warns Epilepsy Drugs May Raise Suicide Risk 10700 1FDA Warns Epilepsy Drugs May Raise Suicide Risk 10700 2FDA Warns Epilepsy Drugs May Raise Suicide Risk 10700 3Changes needed in how federal government evaluates efficiency of research at EPA other agencies 10695 1Changes needed in how federal government evaluates efficiency of research at EPA other agencies 10695 2
...tchison Whampoa backed pharmaceutical and,healthca... Phase II,proof-of-concept study for HMPL-004 in m...ammatory bowel disease. The trial met,its objecti...an,equivalent drop in clinical symptom score to th...ine standard of care in,mild-to-moderate Ulcerativ...
...e du Myelome (IFM),Trial Presented During IMW -, C...ll/ --,Millennium Pharmaceuticals, Inc. today repo...ve Phase III clinical trial evaluating a,VELCADE b...MM),patients. As induction therapy prior to stem c...py produced a high complete remission,/ complete r...
Other Medicine Technology:Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6
Form should always follow function. Thats why EagleVision created the FlexPlug, the only tapered shaft punctum plug with contouring traction ribs. Designed to provide the ultimate in flexibility, fix
...n Prevail's steerable tip, along with various fixe... the curve you need, when you need it. Inject cont...ac venous anatomy, adjust course as needed with ti...h by telescoping the Attain Prevail through a stra...
Attain CS Leads. Navigate minimally angled veins with no tortuosity.
The Hancock® II bioprosthesis from Medtronic has more than 15 years of proven clinical experience. Worldwide clinical studies demonstrate that the freedom from structural valve deterioration with
Medicine Products: